Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 13, 2016 6:45 PM ET


Company Overview of Fidia Farmaceutici s.p.a.

Company Overview

Fidia Farmaceutici s.p.a. researches, develops, manufactures, markets, and sells medicinal products, medical devices, and dietary supplements primarily based on hyaluronic acid and its derivatives. The company’s primary business areas include treatment and management of joint care/musculoskeletal disorders, including osteoarthritis, and advanced wound care/dermo-aesthetics. The company offers dietary supplements, hyaluronic acid sodium salts, diclofenac sodium salts, gingival gels, hyaluronic acid sodium salt for intra-dermal administration, auto cross-linked hyaluronic acid for intra-dermal administration, vaginal bioequilibrant gels, topical gels, cream-impregnated gauze pads for topical u...

Via Ponte della Fabbrica 3/A

Abano Terme, PD 35031


Founded in 1946


39 04 98 23 21 11


39 04 49 81 06 53

Key Executives for Fidia Farmaceutici s.p.a.

Chief Executive Officer
Compensation as of Fiscal Year 2015.

Fidia Farmaceutici s.p.a. Key Developments

Fidia Farmaceutici Signs Partnership Agreement with APR Applied Pharma Research to Market APR Paediatric Products in Italy

Fidia Farmaceutici and APR Applied Pharma Research have entered into a partnership agreement allowing Fidia to market APR paediatric products in Italy. Under the terms of the deal, Fidia will be granted rights to commercialize APR's global over-the-counter (OTC) and prescription brand, Halykoo, which caters for a range of paediatric skin and mucosal health treatments. The Halykoo brand will be available in Italy from 2016. The partnership complements Fidia's existing therapeutic portfolio in the paediatrics market segment.

Similar Private Companies By Industry

Company Name Region
Teva Pharmaceutical Fine Chemicals S.r.l. Europe
Azienda Farmacie Milanesi S.p.A. Europe
Cephalon Italia S.r.L Europe
Friulchem SpA Europe
Gipharma Srl Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Fidia Farmaceutici s.p.a., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at